5LopezGuerra JL,Gomez D,Zhuang Y,et al.Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for nonsmall-cell lung cancer[J].International Journal of Radiation Oncology Biology Physics,2012,83(5):1573-1579.
6Lin Q,Liu Y,Wang N,et al.A modified phase I trial of radiation dose escalation in 3Dconformal radiation therapy with concurrent vinorelbine and carboplatin chemotherapy for non-small-cell lung cancer[J].Journal of Radiation Research,2013,54(1):126-134.
7Jiang ZQ,Yang K,Komaki R,et al.Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer:The MD Anderson experience[J].International Journal of Radiation Oncology Biology Physics,2012,83(1):332-339.
8Gill KK,Kaddoumi A,Nazzal S,et al.Mixed micelles of PEG 2000-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide:Enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer(NSCLC)cell lines[J].European Journal of Pharmaceutical Sciences,2012,46(1/2):64-71.
9Meng X,Sun X,Mu D,et al.Noninvasive evaluation of microscopic tumor extensions using standardized uptake value and metabolic tumor volume in non-small-cell lung cancer[J].International Journal of Radiation Oncology Biology Physics,2012,82(2):960-966.
10Tada T,Chiba Y,Tsujino K,et al.A phase i study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for stage III non-small cell lung cancer:WJTOG 3305[J].International Journal of Radiation Oncology,Biology,Physics,2012,83(1):327-331.
